These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 25046270)
21. A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1. Kydd JH; Davis-Poynter NJ; Birch J; Hannant D; Minke J; Audonnet JC; Antczak DF; Ellis SA J Gen Virol; 2006 Sep; 87(Pt 9):2507-2515. PubMed ID: 16894188 [TBL] [Abstract][Full Text] [Related]
22. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome. Osterrieder N; Van de Walle GR Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764 [TBL] [Abstract][Full Text] [Related]
23. Major histocompatibility complex class I downregulation induced by equine herpesvirus type 1 pUL56 is through dynamin-dependent endocytosis. Huang T; Lehmann MJ; Said A; Ma G; Osterrieder N J Virol; 2014 Nov; 88(21):12802-15. PubMed ID: 25165105 [TBL] [Abstract][Full Text] [Related]
24. Identification of Host Factors Associated with the Development of Equine Herpesvirus Myeloencephalopathy by Transcriptomic Analysis of Peripheral Blood Mononuclear Cells from Horses. Zarski LM; Giessler KS; Jacob SI; Weber PSD; McCauley AG; Lee Y; Soboll Hussey G Viruses; 2021 Feb; 13(3):. PubMed ID: 33668216 [TBL] [Abstract][Full Text] [Related]
25. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488 [TBL] [Abstract][Full Text] [Related]
26. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus. Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066 [TBL] [Abstract][Full Text] [Related]
27. Impact of equine herpesvirus type 1 (EHV-1) infection on the migration of monocytic cells through equine nasal mucosa. Baghi HB; Nauwynck HJ Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):321-9. PubMed ID: 25456193 [TBL] [Abstract][Full Text] [Related]
28. Effect of equine herpesvirus type 1 (EHV-1) infection of nasal mucosa epithelial cells on integrin alpha 6 and on different components of the basement membrane. Bannazadeh Baghi H; Nauwynck HJ Arch Virol; 2016 Jan; 161(1):103-10. PubMed ID: 26497179 [TBL] [Abstract][Full Text] [Related]
29. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Paillot R; Daly JM; Juillard V; Minke JM; Hannant D; Kydd JH Vaccine; 2005 Aug; 23(36):4541-51. PubMed ID: 15913852 [TBL] [Abstract][Full Text] [Related]
30. Bacterial Toxins from Van Crombrugge E; Vanbeylen E; Van Cleemput J; Van den Broeck W; Laval K; Nauwynck H Viruses; 2022 Jan; 14(1):. PubMed ID: 35062352 [TBL] [Abstract][Full Text] [Related]
31. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract. Breathnach CC; Yeargan MR; Timoney JF; Allen GP Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871 [TBL] [Abstract][Full Text] [Related]
32. The neuropathogenic T953 strain of equine herpesvirus-1 inhibits type-I IFN mediated antiviral activity in equine endothelial cells. Sarkar S; Balasuriya UB; Horohov DW; Chambers TM Vet Microbiol; 2016 Feb; 183():110-8. PubMed ID: 26790943 [TBL] [Abstract][Full Text] [Related]
33. Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells. Laval K; Favoreel HW; Poelaert KC; Van Cleemput J; Nauwynck HJ J Virol; 2015 Nov; 89(21):10912-23. PubMed ID: 26292328 [TBL] [Abstract][Full Text] [Related]
34. Immunological characterization of the equine airway epithelium and of a primary equine airway epithelial cell culture model. Quintana AM; Landolt GA; Annis KM; Hussey GS Vet Immunol Immunopathol; 2011 Apr; 140(3-4):226-36. PubMed ID: 21292331 [TBL] [Abstract][Full Text] [Related]
35. Absence of viral antigens on the surface of equine herpesvirus-1-infected peripheral blood mononuclear cells: a strategy to avoid complement-mediated lysis. van der Meulen KM; Nauwynck HJ; Pensaert MB J Gen Virol; 2003 Jan; 84(Pt 1):93-97. PubMed ID: 12533704 [TBL] [Abstract][Full Text] [Related]
36. A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1. Zarski LM; Vaala WE; Barnett DC; Bain FT; Soboll Hussey G Front Vet Sci; 2021; 8():674850. PubMed ID: 34179166 [TBL] [Abstract][Full Text] [Related]
37. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment. Dunowska M N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778 [TBL] [Abstract][Full Text] [Related]
39. The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires. Bergmann T; Moore C; Sidney J; Miller D; Tallmadge R; Harman RM; Oseroff C; Wriston A; Shabanowitz J; Hunt DF; Osterrieder N; Peters B; Antczak DF; Sette A Immunogenetics; 2015 Nov; 67(11-12):675-89. PubMed ID: 26399241 [TBL] [Abstract][Full Text] [Related]
40. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals. Bell SA; Balasuriya UB; Gardner IA; Barry PA; Wilson WD; Ferraro GL; MacLachlan NJ Vet Microbiol; 2006 Sep; 116(4):249-57. PubMed ID: 16774810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]